This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as a Hybrid Event from September 20-30, 2021
Live Digital Agenda Runs 11am-3pm EST from Sept 28-30Boston Convention and Exhibition Center

Eva Rubio-Marrero, Ph.D.
Senior Scientist at Bristol Myers Squibb


Eva Rubio-Marrero, Ph.D., works at Bristol Myers Squibb (BMS) in New Jersey site in the Cell Line Development and ‘Omics group in the Biologics Department. She helped to develop the CLD platform in Celgene company before it was acquired by BMS in 2019 and has worked with multiple projects for monoclonal and bispecific antibodies. Prior to Celgene (now BMS), Eva was pursuing her doctoral degree where she had the opportunity to develop cell lines expressing proteins linked to autism spectrum disorders (ASD) in mammalian system and studied the function of these proteins in the nervous system. Eva continues contributing to CLD exploring new technologies that helps overcome challenges in the CLD process.

Agenda Sessions

  • ROOM 253C: Effective Strategies To Help Speed Up Cell Line Development

  • ROOM 253C: PANEL: Speeding Up Cell Line Development via Workflow Optimization Techniques and Technologies